[go: up one dir, main page]

ATE426661T1 - Somatische pluripotente zellen - Google Patents

Somatische pluripotente zellen

Info

Publication number
ATE426661T1
ATE426661T1 AT02257930T AT02257930T ATE426661T1 AT E426661 T1 ATE426661 T1 AT E426661T1 AT 02257930 T AT02257930 T AT 02257930T AT 02257930 T AT02257930 T AT 02257930T AT E426661 T1 ATE426661 T1 AT E426661T1
Authority
AT
Austria
Prior art keywords
pluripotent cells
cell
somatic pluripotent
develops
somatic
Prior art date
Application number
AT02257930T
Other languages
English (en)
Inventor
Shiaw-Min Hwang
Original Assignee
Food Industry Res And Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Food Industry Res And Dev filed Critical Food Industry Res And Dev
Application granted granted Critical
Publication of ATE426661T1 publication Critical patent/ATE426661T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0607—Non-embryonic pluripotent stem cells, e.g. MASC
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/873—Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/13—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells
    • C12N2506/1346—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells
    • C12N2506/1353—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells from bone marrow mesenchymal stem cells (BM-MSC)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/13—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells
    • C12N2506/1346—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells
    • C12N2506/1369—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells from blood-borne mesenchymal stem cells, e.g. MSC from umbilical blood

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT02257930T 2002-07-26 2002-11-18 Somatische pluripotente zellen ATE426661T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39888302P 2002-07-26 2002-07-26
US10/287,362 US7422736B2 (en) 2002-07-26 2002-11-04 Somatic pluripotent cells

Publications (1)

Publication Number Publication Date
ATE426661T1 true ATE426661T1 (de) 2009-04-15

Family

ID=30002798

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02257930T ATE426661T1 (de) 2002-07-26 2002-11-18 Somatische pluripotente zellen

Country Status (12)

Country Link
US (1) US7422736B2 (de)
EP (1) EP1384775B1 (de)
JP (1) JP4685322B2 (de)
KR (1) KR100879079B1 (de)
CN (1) CN1470633B (de)
AT (1) ATE426661T1 (de)
AU (1) AU2002302089B2 (de)
CA (1) CA2413275C (de)
DE (1) DE60231708D1 (de)
ES (1) ES2322334T3 (de)
SG (1) SG129236A1 (de)
TW (1) TWI316962B (de)

Families Citing this family (90)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080152629A1 (en) * 2000-12-06 2008-06-26 James Edinger Placental stem cell populations
US7311905B2 (en) 2002-02-13 2007-12-25 Anthrogenesis Corporation Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
DK1349918T3 (da) 2000-12-06 2014-11-10 Anthrogenesis Corp Fremgangsmåde til indsamling af stamceller fra moderkagen
KR101132545B1 (ko) * 2001-02-14 2012-04-02 안트로제네시스 코포레이션 산후 포유류의 태반, 이의 용도 및 태반 줄기세포
CA3046566A1 (en) * 2001-02-14 2002-08-22 Anthrogenesis Corporation Post-partum mammalian placental stem cells for use in the treatment of neurological or renal diseases and disorders
EP1571910A4 (de) 2002-11-26 2009-10-28 Anthrogenesis Corp Zytotherapeutika, zytotherapeutischeeinheiten und behandlungsverfahren, bei denen diese verwendet werden
CA2515594A1 (en) * 2003-02-13 2004-08-26 Anthrogenesis Corporation Use of umbilical cord blood to treat individuals having a disease, disorder or condition
GB0321337D0 (en) * 2003-09-11 2003-10-15 Massone Mobile Advertising Sys Method and system for distributing advertisements
EP1682654A2 (de) * 2003-11-10 2006-07-26 Amgen Inc. Verfahren zur verwendung von g-csf mobilisierten c-kit+ zellen in der herstellung von embryoidkörper-ähnlichen zellmassen zur gewebewiederherstellung und zur therapie von kardiomyopathie
KR20110116225A (ko) * 2003-12-02 2011-10-25 셀진 코포레이션 혈색소병증　및　빈혈의　치료　및　관리를　위한　방법및　조성물
WO2005070011A2 (en) * 2004-01-23 2005-08-04 Advanced Cell Technology, Inc. Improved modalities for the treatment of degenerative diseases of the retina
US7794704B2 (en) 2004-01-23 2010-09-14 Advanced Cell Technology, Inc. Methods for producing enriched populations of human retinal pigment epithelium cells for treatment of retinal degeneration
US20050186672A1 (en) * 2004-01-27 2005-08-25 Reliance Life Sciences Pvt. Ltd. Tissue system with undifferentiated stem cells derived from corneal limbus
BRPI0506536C1 (pt) * 2004-02-26 2007-05-22 Reliance Life Sciences Pvt Ltd neurÈnios dopaminérgicos derivados do limbus corneal, métodos de isolamento e usos dos mesmos
US8187875B2 (en) * 2004-02-26 2012-05-29 Reliance Life Sciences Pvt. Ltd. Dopaminergic neurons derived from corneal limbus, methods of isolation and uses thereof
US20060216821A1 (en) * 2004-02-26 2006-09-28 Reliance Life Sciences Pvt. Ltd. Pluripotent embryonic-like stem cells derived from corneal limbus, methods of isolation and uses thereof
CA2856662C (en) 2005-10-13 2017-09-05 Anthrogenesis Corporation Immunomodulation using placental stem cells
KR100697326B1 (ko) * 2005-12-02 2007-03-20 재단법인서울대학교산학협력재단 Ｏｃｔ４ 발현능을 가지는 제대혈 유래 다분화능 성체줄기세포 및 그의 제조방법
US7714562B2 (en) * 2005-12-05 2010-05-11 Panasonic Corporation Hysteretic switching regulator
WO2007067280A2 (en) * 2005-12-08 2007-06-14 University Of Louisville Research Foundation, Inc. Very small embryonic-like (vsel) stem cells and methods of isolating and using the same
US9155762B2 (en) * 2005-12-08 2015-10-13 University Of Louisville Research Foundation, Inc. Uses and isolation of stem cells from bone marrow
US8278104B2 (en) 2005-12-13 2012-10-02 Kyoto University Induced pluripotent stem cells produced with Oct3/4, Klf4 and Sox2
BRPI0619794B8 (pt) 2005-12-13 2022-06-14 Univ Kyoto Uso de um fator de reprogramação, agente para a preparação de uma célula-tronco pluripotente induzida a partir de uma célula somática e métodos para preparar uma célula- tronco pluripotente induzida método e para preparar uma célula somática e uso de células-tronco pluripotentes induzidas
US8129187B2 (en) 2005-12-13 2012-03-06 Kyoto University Somatic cell reprogramming by retroviral vectors encoding Oct3/4. Klf4, c-Myc and Sox2
PT2471906T (pt) * 2005-12-29 2019-02-06 Celularity Inc Populações de células estaminais da placenta
CN101389754A (zh) 2005-12-29 2009-03-18 人类起源公司 胎盘干细胞和第二来源干细胞的联合培养
WO2007117472A2 (en) * 2006-04-07 2007-10-18 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Adult bone marrow cell transplantation to testes creation of transdifferentiated testes germ cells, leydig cells and sertoli cells
WO2007146123A2 (en) * 2006-06-09 2007-12-21 Anthrogenesis Corporation Placental niche and use thereof to culture stem cells
US7993918B2 (en) * 2006-08-04 2011-08-09 Anthrogenesis Corporation Tumor suppression using placental stem cells
AU2007309447B2 (en) 2006-10-23 2014-04-03 Celularity Inc. Methods and compositions for treatment of bone defects with placental cell populations
CN101657206B (zh) * 2007-02-12 2013-07-03 人类起源公司 利用胎盘干细胞治疗炎性疾病
MX2009008559A (es) 2007-02-12 2009-08-21 Anthrogenesis Corp Hepatocitos y condorcitos de celulas madre de la placenta adherentes, y poblaciones de celulas enriquecidas con celulas madre de la placenta cd34+, cd45-.
US20100172830A1 (en) * 2007-03-29 2010-07-08 Cellx Inc. Extraembryonic Tissue cells and method of use thereof
US8574567B2 (en) 2007-05-03 2013-11-05 The Brigham And Women's Hospital, Inc. Multipotent stem cells and uses thereof
EP2607477B1 (de) 2007-05-03 2020-09-23 The Brigham and Women's Hospital, Inc. Multipotente stammzellen und ihre verwendung
TWM322542U (en) * 2007-05-23 2007-11-21 Universal Scient Ind Co Ltd Testing machine
JP2008307007A (ja) * 2007-06-15 2008-12-25 Bayer Schering Pharma Ag 出生後のヒト組織由来未分化幹細胞から誘導したヒト多能性幹細胞
US9213999B2 (en) 2007-06-15 2015-12-15 Kyoto University Providing iPSCs to a customer
CA2700613C (en) * 2007-09-26 2022-09-20 Celgene Cellular Therapeutics Angiogenic cells from human placental perfusate
EP3524253A1 (de) 2007-09-28 2019-08-14 Celularity, Inc. Tumorsuppression mit menschlichem plazentaperfusat und menschlichen natürlichen killerzellen eines zwischenproduktes aus der plazenta
WO2009046377A2 (en) * 2007-10-04 2009-04-09 Medistem Laboratories, Inc. Compositions and methods of stem cell therapy for autism
AU2008312007A1 (en) * 2007-10-12 2009-04-23 Advanced Cell Technology, Inc. Improved methods of producing RPE cells and compositions of RPE cells
EP2214497A4 (de) * 2007-10-30 2010-11-24 Univ Louisville Res Found Verwendungen und isolation von vsel (very small embryonic-like) stammzellen
KR20100100855A (ko) * 2007-11-07 2010-09-15 안트로제네시스 코포레이션 조산 합병증의 치료에 있어서의 제대혈의 용도
GB0805670D0 (en) * 2008-03-28 2008-04-30 Smith & Nephew Increasing the plasticity of stem cells
JP5346925B2 (ja) 2008-05-02 2013-11-20 国立大学法人京都大学 核初期化方法
JP5212977B2 (ja) * 2008-06-10 2013-06-19 国立大学法人福井大学 低酸素培養機器及び無糖培地を用いたがん幹細胞濃縮法
WO2010004989A1 (ja) * 2008-07-07 2010-01-14 タカラバイオ株式会社 多能性幹細胞の製造方法
MX339624B (es) * 2008-08-20 2016-06-02 Anthrogenesis Corp Composiciones mejoradas de celulas y metodos para preparar las mismas.
WO2010021715A1 (en) * 2008-08-20 2010-02-25 Anthrogenesis Corporation Treatment of stroke using isolated placental cells
ES2426241T3 (es) * 2008-08-22 2013-10-22 Anthrogenesis Corporation Métodos y composiciones para el tratamiento de defectos óseos con poblaciones de células placentarias
RU2562154C2 (ru) * 2008-11-19 2015-09-10 Антродженезис Корпорейшн Амниотические адгезивные клетки
EP2375907B1 (de) * 2008-11-21 2019-02-27 Celularity, Inc. Behandlung von krankheiten, störungen oder leiden der lunge mittels plazentazellen
US8394630B2 (en) 2009-01-13 2013-03-12 StemBios Technologies, Inc. Producing a mammalian pluripotent cell population from mammalian blastomere-like stem cells (BLSCs)
IL281453B (en) 2009-11-17 2022-07-01 Astellas Inst For Regenerative Medicine Methods of producing human rpe cells and pharmaceutical preparations of human rpe cells
US8759098B2 (en) 2009-12-04 2014-06-24 Boston Biomedical Research Institute, Inc. Method for cloning pluripotent stem cells
EP3284818B1 (de) * 2010-01-26 2022-03-09 Celularity Inc. Behandlung von knochenbedingten karzinomen mit plazentastammzellen
RS55287B1 (sr) 2010-04-07 2017-03-31 Anthrogenesis Corp Angiogeneza korišćenjem matičnih ćelija iz placente
TW201138792A (en) 2010-04-08 2011-11-16 Anthrogenesis Corp Treatment of sarcoidosis using placental stem cells
JP2013530699A (ja) 2010-06-15 2013-08-01 セルラー ダイナミクス インターナショナル， インコーポレイテッド 生物学的応答の調査のための既製の幹細胞モデルの概要
JP5897002B2 (ja) 2010-07-07 2016-04-13 セルラー ダイナミクス インターナショナル， インコーポレイテッド プログラミングによる内皮細胞の産生
AU2011279201B2 (en) 2010-07-13 2016-01-21 Celularity Inc. Methods of generating natural killer cells
EP3569696A1 (de) 2010-08-04 2019-11-20 Stembios Technologies, Inc. Somatische stammzellen
EP2625264B1 (de) 2010-10-08 2022-12-07 Terumo BCT, Inc. Verfahren und systeme für züchtung und ernte von zellen in einem hohlfaser-bioreaktorsystem mit steuerungsbedingungen
WO2012092485A1 (en) 2010-12-31 2012-07-05 Anthrogenesis Corporation Enhancement of placental stem cell potency using modulatory rna molecules
CA2826386C (en) 2011-02-08 2020-04-28 Cellular Dynamics International, Inc. Hematopoietic precursor cell production by programming
WO2012166844A2 (en) 2011-06-01 2012-12-06 Anthrogenesis Corporation Treatment of pain using placental stem cells
WO2013055476A1 (en) 2011-09-09 2013-04-18 Anthrogenesis Corporation Treatment of amyotrophic lateral sclerosis using placental stem cells
TWI614340B (zh) 2011-09-28 2018-02-11 幹細胞生物科技股份有限公司 體幹細胞及其製備方法
CN105142651A (zh) 2013-02-05 2015-12-09 人类起源公司 来自胎盘的自然杀伤细胞
US20140242595A1 (en) 2013-02-22 2014-08-28 Cellular Dynamics International, Inc. Hepatocyte production via forward programming by combined genetic and chemical engineering
JP6602288B2 (ja) 2013-04-03 2019-11-06 フジフィルム セルラー ダイナミクス，インコーポレイテッド 浮遊液中で内胚葉前駆細胞を培養するための方法および組成物
EP3068867B1 (de) 2013-11-16 2018-04-18 Terumo BCT, Inc. Zellenexpansion in einem bioreaktor
JP6783143B2 (ja) 2014-03-25 2020-11-11 テルモ ビーシーティー、インコーポレーテッド 培地の受動的補充
US20170107486A1 (en) 2014-04-21 2017-04-20 Cellular Dynamics International, Inc. Hepatocyte production via forward programming by combined genetic and chemical engineering
WO2016049421A1 (en) 2014-09-26 2016-03-31 Terumo Bct, Inc. Scheduled feed
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
US11312940B2 (en) 2015-08-31 2022-04-26 University Of Louisville Research Foundation, Inc. Progenitor cells and methods for preparing and using the same
US11072777B2 (en) 2016-03-04 2021-07-27 University Of Louisville Research Foundation, Inc. Methods and compositions for ex vivo expansion of very small embryonic-like stem cells (VSELs)
WO2017205667A1 (en) 2016-05-25 2017-11-30 Terumo Bct, Inc. Cell expansion
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
EP3656841A1 (de) 2017-03-31 2020-05-27 Terumo BCT, Inc. Zellexpansion
US12234441B2 (en) 2017-03-31 2025-02-25 Terumo Bct, Inc. Cell expansion
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
JP2024511064A (ja) 2021-03-23 2024-03-12 テルモ ビーシーティー、インコーポレーテッド 細胞捕獲及び増殖
CA3216719A1 (en) 2021-05-03 2022-11-10 Astellas Institute For Regenerative Medicine Methods of generating mature corneal endothelial cells
EP4334435A1 (de) 2021-05-07 2024-03-13 Astellas Institute for Regenerative Medicine Verfahren zur erzeugung reifer hepatozyten
US12209689B2 (en) 2022-02-28 2025-01-28 Terumo Kabushiki Kaisha Multiple-tube pinch valve assembly
IL318429A (en) 2022-08-23 2025-03-01 Astellas Inst For Regenerative Medicine Photoreceptor rescue cell (PRC) compositions and methods for treating eye disorders

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5453357A (en) * 1992-10-08 1995-09-26 Vanderbilt University Pluripotential embryonic stem cells and methods of making same
US5843780A (en) * 1995-01-20 1998-12-01 Wisconsin Alumni Research Foundation Primate embryonic stem cells
CA2852534A1 (en) * 1999-08-05 2001-02-15 Abt Holding Company Multipotent adult stem cells and methods for isolation
AU6400100A (en) 1999-08-10 2001-03-05 Dial Corporation, The Transparent/translucent moisturizing/cosmetic/personal cleansing bar
EP1218489B1 (de) 1999-09-24 2009-03-18 Cybios LLC Pluripotent embryonale stammzellen-ähnliche zellen, zusammensetzungen und ihre vervendungen
GB0026252D0 (en) 2000-10-26 2000-12-13 Univ Edinburgh Pluripotential stem cells
CA2434362A1 (en) 2001-01-20 2002-07-25 Cardion Ag Pluripotent adult stem cells derived from regenerative tissue
JP2004529621A (ja) 2001-02-14 2004-09-30 ティー ファークト，レオ 多能性成体幹細胞、その起源、それを得る方法および維持する方法、それを分化させる方法、その使用法、ならびにそれ由来の細胞
US20050032207A1 (en) 2001-09-12 2005-02-10 Anna Wobus Method for isolating, culturing and differentiating intestinal stem cells for therapeutic use

Also Published As

Publication number Publication date
DE60231708D1 (de) 2009-05-07
KR100879079B1 (ko) 2009-01-15
CN1470633B (zh) 2010-09-29
EP1384775B1 (de) 2009-03-25
AU2002302089A1 (en) 2004-02-12
KR20040010029A (ko) 2004-01-31
AU2002302089B2 (en) 2008-08-14
US7422736B2 (en) 2008-09-09
US20040018617A1 (en) 2004-01-29
JP4685322B2 (ja) 2011-05-18
SG129236A1 (en) 2007-02-26
TW200401828A (en) 2004-02-01
JP2004057198A (ja) 2004-02-26
CA2413275C (en) 2014-09-30
CA2413275A1 (en) 2004-01-26
TWI316962B (en) 2009-11-11
CN1470633A (zh) 2004-01-28
ES2322334T3 (es) 2009-06-19
EP1384775A1 (de) 2004-01-28

Similar Documents

Publication Publication Date Title
DE60231708D1 (de) Somatische pluripotente Zellen
EP1576089A4 (de) Expansion erneuerbarer stammzellpopulationen
ATE491022T1 (de) Konditionell immortalisierte adulte langzeit- stammzellen und verfahren zur herstellung und verwendung von solchen zellen
DE60002185D1 (de) Transplantation von hämatopoietischen zellen
DE60138029D1 (de) Verfahren zur herstellung von biopterinen
WO2004016742A3 (en) α(1,3)-GALACTOSYLTRANSFERASE NULL CELLS, METHODS OF SELECTING AND α(1,3)-GALACTOSYLTRANSFERASE NULL SWINE PRODUCED THEREFROM
GB0208041D0 (en) Method of culturing animal cells
HK1124363A1 (en) Transgenic mammal carrying ganp gene transferred thereinto and utilization thereof
DE59700928D1 (de) Sphärische keramikformkörper, verfahren zu ihrer herstellung sowie deren verwendung
ATE431416T1 (de) Enzymatische synthese von deoxyribonucleotiden
DE60009210D1 (de) Vorrichtung zur Herstellung von Wasserstoff
ATE452186T1 (de) Cephalosporin-c-acylase-mutante und verfahren zur herstellung von 7-aca damit
WO2002068635A3 (en) Methods of inhibiting expression of a target gene in mammalian cells
EA200100129A1 (ru) Способ получения гидроксиметилтиобутановой кислоты
PL367306A1 (pl) Szczepionki na bazie autologicznych komórek T i sposoby ich otrzymywania
ATE335824T1 (de) Isolierte luziferasen sowie deren verwendung
NZ508602A (en) The production of primmorphs from disassociated cells of sponges, corals and other invertebrates, and use thereof
TW200607141A (en) Cell having A/S label and method for producing the same
DE60126244D1 (de) Verfahren zur Herstellung von Vieh aus Zellen einer etablierten Zelllinie
BRPI0407685A (pt) bateria que contém material fibroso
CY1109583T1 (el) Κυτοκινες θηλαστικων, αντιστοιχα αντιδραστηρια
EP1216298A4 (de) Verfahren zur herstellung von geklonten und transgenen säugetieren
PT1064265E (pt) Sintese de 3-amino-2-cloro-4-metilpiridina a partir de malononitrilo e acetona
DE50109809D1 (de) Verfahren zur Herstellung von D- oder L-Menthol
WO2004087954A3 (en) Cell cycle related markers

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties